Cell Care Research and TrialsCell Care is partnering with The Children’s Hospital at Westmead, New South Wales, in a world–first study investigating the potential of cord blood to prevent or delay the onset of type 1 diabetes (T1D) in children at high risk of developing the disease.
The CORD study is currently recruiting children between 1 and 14 years of age who are at high risk of developing T1D – where a parent, sibling or other close family members (1st or 2nd degree relatives) have T1D. The study is available to families who have stored cord blood or who are currently expecting a baby and planning cord blood storage.
If you have a family history of Type 1 diabetes and are expecting a child, you can request your cord blood and tissue information pack here.
For more information about the CORD study contact the CORD Study coordinator/nurse at The Children's Hospital Westmead;
Email: SCHN-CHW-CORD@health.nsw.gov.au
Phone: +61 (2) 9845 3512
The CORD study has been approved by the Sydney Children's Hospitals Network Human Research Ethics Committee and is listed on the Australian and New Zealand Clinical Trial Register.
Cell Care supports research at the Monash Institute of Medical Research - Ritchie Centre, where scientists are investigating the underlying causes of newborn brain injury – which predominantly occurs either during pregnancy or at the time of birth. Their aim is to develop safe and effective therapies to prevent or repair brain injury, thereby reducing the incidence of cerebral palsy.
Read more about the Cell Care Senior Research Fellowship at The Ritchie Centre.